The SSPC mission is "to position Ireland as a global hub for process innovation and advanced manufacturing in the pharmaceutical industry". SSPC vision is to be "recognised as the leading centre of excelence shaping the future of global pharmaceuticals".

The SSPC transcends company and academic boundaries and is the largest research collaboration in Ireland, and one of the largest globally, within the pharmaceutical area. The SSPC supports over 300 active members, across academia and industry on a national and international basis. 

Launched in July 2013, the Synthesis and Solid State Pharmaceutical Centre (SSPC), supporting 90 top-class researchers, is the largest research collaboration in Ireland, and one of the largest globally, within the pharmaceutical area. The SSPC represents a significant combined Science Foundation Ireland and industry investment of €42 million. Building upon the success of the Cluster (2007-2013), the SSPC research programme now spans the entire pharmaceutical production chain from synthesis of the molecule, to the isolation of the material, and the formulation of the medicine. In other words, the SSPC research programme focuses upon developing more environmentally sustainable methods for drug manufacturing; increasing the range of medicines available to the public; and reducing drug manufacturing costs.